KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $2.09.

  • Johnson & Johnson's EPS (Weighted Average and Diluted) rose 4822.7% to $2.09 in Q4 2025 from the same period last year, while for Dec 2025 it was $11.04, marking a year-over-year increase of 9067.36%. This contributed to the annual value of $11.03 for FY2025, which is 9050.09% up from last year.
  • As of Q4 2025, Johnson & Johnson's EPS (Weighted Average and Diluted) stood at $2.09, which was up 4822.7% from $2.12 recorded in Q3 2025.
  • In the past 5 years, Johnson & Johnson's EPS (Weighted Average and Diluted) registered a high of $10.21 during Q4 2023, and its lowest value of -$0.19 during Q2 2023.
  • Over the past 5 years, Johnson & Johnson's median EPS (Weighted Average and Diluted) value was $1.74 (recorded in 2022), while the average stood at $1.95.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 12947.27% in 2023, then skyrocketed by 444959.52% in 2024.
  • Johnson & Johnson's EPS (Weighted Average and Diluted) (Quarter) stood at $1.37 in 2021, then rose by 22.63% to $1.68 in 2022, then crashed by 101.93% to -$0.03 in 2023, then surged by 4449.6% to $1.41 in 2024, then soared by 48.23% to $2.09 in 2025.
  • Its EPS (Weighted Average and Diluted) was $2.09 in Q4 2025, compared to $2.12 in Q3 2025 and $2.29 in Q2 2025.